Masimo's non-GAAP EPS of $0.98 topped internal guidance. Healthcare revenue surged by 11.5% year over year to $343.3 million. Litigation with Apple heighten financial uncertainties for the company ...

Masimo stock broke out, touching an eight-month high Monday after the company said it could potentially separate its audio and consumer-facing business. Please watch the video at Investors.com ...

Masimo MASI2.20%increase; green up pointing triangle said Joe Kiani, who previously informed the board of his decision to resign as chief executive, has been terminated by the company. Kiani’s ...

Masimo (NASDAQ:MASI) is set to give its latest quarterly earnings report on Tuesday, 2024-11-05. Here's what investors need to know before the announcement. Analysts estimate that Masimo will ...

A federal jury ruled Friday that Masimo smartwatches infringed Apple patents, but Apple isn’t getting a big payday. Bloomberg Law reports that the company was only seeking the statutory minimum ...

Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care... by Taking Noninvasive Monitoring to New Sites and Applications, rainbow, SpHb, SpOC, SpCO ...

Apple and Masimo are back in a California court this week for a bench trial that will see Masimo arguing that Apple illegally poached its employees and stole trade secrets when developing the ...

Nabaparna Bhattacharya Masimo Surges 8.7%: Is This an Indication of Further Gains? Masimo (NASDAQ: MASI) shares soared 8.7% in the last trading session to close at $121.42. The move was backed by ...

Masimo announced that its CEO Joe Kiani informed the board of directors that he has stepped down from his post. He was replaced by board member Michelle Brennan on an interim basis. The change is ...

Masimo (NASDAQ: MASI) will release third quarter 2024 financial results for the period ended September 28, 2024, after the market closes on Tuesday, November 5, 2024. The conference call to review ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...